Trials / Completed
CompletedNCT02935036
Efficacy Study in Patients With Acne Vulgaris.
A Multi-center, Double-blind, Randomized, Placebo Controlled, Parallel-group Study to Evaluate the Efficacy and Safety of ADPS in the Treatment of Acne Vulgaris
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 294 (actual)
- Sponsor
- Sun Pharmaceutical Industries, Inc. · Industry
- Sex
- All
- Age
- 9 Years
- Healthy volunteers
- Accepted
Summary
Safety and efficacy study in patients with acne vulgaris
Detailed description
randomized, double-blind, placebo controlled, parallel-group, multiple-center study to evaluate the efficacy and safety of ADPS in the treatment of acne vulgaris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ADPS topical product | topical product |
| DRUG | Placebo Control | topical product |
Timeline
- Start date
- 2016-10-03
- Primary completion
- 2017-01-24
- Completion
- 2017-03-21
- First posted
- 2016-10-17
- Last updated
- 2018-10-18
- Results posted
- 2018-09-18
Source: ClinicalTrials.gov record NCT02935036. Inclusion in this directory is not an endorsement.